Long noncoding RNA ANRIL alleviates hypoxia‐induced pulmonary microvascular endothelial cell damage
European Journal of Clinical Investigation · 2024
DOI: 10.1111/eci.14202 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Yijin Qi und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Xizang Minzu University, Xianyang, Shaanxi, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Apoptosis, Endothelial Cells, Cell Proliferation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Major Training Program of Xizang Minzu University for Nationalities, Special Project of Central Government Guiding Local Science and Technology Development of Xizang (Tibet) Autonomous Region, Science and Technology Major Project of Tibetan Autonomous Region of China.
Abstract (Originalsprache)
Background
High‐altitude pulmonary oedema (HAPE) is a form of noncardiogenic pulmonary oedema. Studies have found that long noncoding RNA (lncRNA) plays an important role in HAPE. ANRIL is significant in pulmonary illnesses, which implies that alterations in ANRIL expression levels may be involved in the beginning and development of HAPE. However, the specific mechanism is indistinct. The present study is meant to explore the effect and mechanism of ANRIL on hypoxic‐induced injury of pulmonary microvascular endothelial cells (PMEVCs).
Methods
In the hypoxic model of PMVECs, overexpression of ANRIL or knockdown of miR‐181c‐5p was performed to assess cell proliferation, apoptosis, and migration. Furthermore, the levels of apoptosis‐related proteins, inflammatory factors, and vascular active factors were also measured.
Results
The results showed that, after 24 h of hypoxia, PMVECs proliferation and migration were suppressed in comparison to the control group, along with an increase in apoptosis, a decrease in the expression of ANRIL, and an increase in the expression of miR‐181c‐5p (all p < .05). The damage caused by hypoxia in PMVECs can be lessened by overexpressing ANRIL, which also inhibits the production of TNF‐α, iNOS, and VEGF as well as BAX and cleaved caspase‐3 (all p < .05). Further experimental results showed that overexpression of ANRIL and knockdown of miR‐181c‐5p had the same protection against hypoxic injury in PMVECs (all p < .05).
Conclusions
Our study suggests that ANRIL may prevent hypoxia injury to PMVECs in HAPE through the negative regulation of miR‐181c‐5p.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Xizang Minzu University, Xianyang, Shaanxi, China.
ORCID-Profile: Dongya Yuan
Förderung
- Major Training Program of Xizang Minzu University for Nationalities
- Special Project of Central Government Guiding Local Science and Technology Development of Xizang (Tibet) Autonomous Region
- Science and Technology Major Project of Tibetan Autonomous Region of China
- Natural Science Foundation of Tibet Autonomous Region
Zitieren
APA
Qi, Y., Chen, M., Zhang, T., Zhao, B., Jin, T., & Yuan, D. (2024). Long noncoding RNA ANRIL alleviates hypoxia‐induced pulmonary microvascular endothelial cell damage. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14202
Vancouver
Qi Y, Chen M, Zhang T, Zhao B, Jin T, Yuan D. Long noncoding RNA ANRIL alleviates hypoxia‐induced pulmonary microvascular endothelial cell damage. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14202
BibTeX
@article{Qi2024,
author = {Qi, Yijin and Chen, Mingyue and Zhang, Tianyi and Zhao, Beibei and Jin, Tianbo and Yuan, Dongya},
title = {Long noncoding RNA ANRIL alleviates hypoxia‐induced pulmonary microvascular endothelial cell damage},
journal = {European Journal of Clinical Investigation},
year = {2024},
doi = {10.1111/eci.14202}
}
EUVIMED